StoneX Maintains IonQ Buy Rating and $60 Price Target

StoneX has reiterated its 'Buy' rating and $60 price target for quantum computing firm IonQ (IONQ), signaling confidence in the company's long-term growth. This stance arrives as Wall Street analysts remain divided on the company's valuation following strategic updates delivered during its September 8, 2026, Investor Day.

Following the event, analyst sentiment has diverged, reflecting uncertainty regarding the company’s transition toward commercial scale. Some firms have trimmed their expectations, while others have moved in the opposite direction.

Analyst Sentiment Divergence

The range of analyst targets highlights the volatility in how the market is pricing IonQ's future performance:

• B. Riley: Maintained a $100 price target, the most optimistic among major analysts.
• Jefferies: Raised its target to $80 from $75.
• Mizuho: Lowered its target to $52 from $61.

This spread in targets, which ranges from $52 to $100, underscores the difficulty in valuing companies in the quantum sector. Revenue growth in this industry is often tied to long-term research and development cycles rather than immediate, predictable cash flows.

Financial Outlook and Product Strategy

The recent analyst adjustments follow IonQ’s updated financial guidance, which projects 2026 combined-company revenue between $450 million and $460 million. This guidance incorporates revenue contributions from the company's acquisition of SkyWater Technology, a strategic move intended to improve IonQ’s manufacturing and supply chain capabilities.

During the Investor Day, the company also unveiled the 'Superion 256' platform. IonQ describes this as its sixth-generation quantum computing system and the foundational architecture for its future product roadmap. The platform is designed to scale quantum operations, which the company claims is a necessary step for achieving fault-tolerant quantum computing in commercial enterprise environments.

What Is at Stake

For investors and market participants, the divergence in analyst targets reflects a debate over IonQ’s ability to integrate its recent acquisitions while scaling its proprietary hardware. The company is currently attempting to balance the high capital expenditures required for quantum research with the need to demonstrate consistent revenue growth to justify its market valuation. Analysts are now monitoring whether the Superion 256 platform can move from announcement to broad commercial adoption, a transition that will likely dictate whether the firm reaches the upper or lower bounds of current price targets.